| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 55.447 | 40.811 | 66.953 | 45.160 | 49.662 | 36.967 | 41.144 | 44.607 | 103.410 | 52.762 |
| Total Income - EUR | 55.792 | 46.234 | 67.143 | 45.360 | 49.798 | 37.009 | 60.613 | 119.022 | 180.830 | 121.402 |
| Total Expenses - EUR | 49.790 | 44.290 | 54.209 | 44.633 | 48.328 | 34.964 | 51.134 | 111.860 | 159.118 | 113.107 |
| Gross Profit/Loss - EUR | 6.002 | 1.944 | 12.934 | 728 | 1.470 | 2.045 | 9.479 | 7.162 | 21.713 | 8.295 |
| Net Profit/Loss - EUR | 4.329 | 1.530 | 12.258 | 274 | 998 | 1.705 | 9.096 | 6.772 | 20.929 | 7.836 |
| Employees | 3 | 3 | 3 | 2 | 2 | 2 | 2 | 3 | 2 | 3 |
Check the financial reports for the company - Bioanalysis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 17.461 | 734 | 324 | 168 | 152 | 3.518 | 4.529 | 2.962 | 2.101 | 37.406 |
| Current Assets | 88.101 | 94.057 | 72.546 | 73.087 | 67.722 | 71.182 | 245.845 | 195.592 | 111.296 | 794.432 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 310 | 303 | 305 | 11.530 | 11.465 |
| Receivables | 63.695 | 57.806 | 57.578 | 64.309 | 60.114 | 62.032 | 235.375 | 194.036 | 87.770 | 751.713 |
| Cash | 24.405 | 36.251 | 14.968 | 8.778 | 7.608 | 8.840 | 10.166 | 1.251 | 11.997 | 31.254 |
| Shareholders Funds | 97.919 | 60.465 | 71.700 | 70.659 | 70.288 | 70.660 | 78.190 | 85.204 | 99.810 | 98.215 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.816 | 34.457 | 1.607 | 2.956 | 679 | 6.061 | 8.182 | 22.449 | 3.196 | 51.946 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 165.239 | 91.464 | 14.356 | 686.822 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Bioanalysis Srl